sponsored
PatientsVille.com Logo

PatientsVille

Fluorouracil Interstitial Lung Disease Side Effects

Fluorouracil Interstitial Lung Disease Side Effect Reports


The following Fluorouracil Interstitial Lung Disease side effect reports were submitted by healthcare professionals and consumers.

This information will help you understand how side effects, such as Interstitial Lung Disease, can occur, and what you can do about them.

A side effect could appear soon after you start Fluorouracil or it might take time to develop.



Interstitial Lung Disease

This Interstitial Lung Disease side effect was reported by a health professional from JP. A 58-year-old female patient (weight:NA) experienced the following symptoms/conditions: breast cancer. The patient was prescribed Fluorouracil (fluorouracil) (fluorouracil) (dosage: NA), which was started on NS. Concurrently used drugs:
  • Paclitaxel (paclitaxel) (paclitaxel)
  • Epirubicin (epirubicin) (epirubicin)
  • Cyclophosphamide (cyclophosphamide) (cyclophosphamide)
When starting to take Fluorouracil (fluorouracil) (fluorouracil) the consumer reported the following symptoms:
  • Interstitial Lung Disease
The patient was hospitalized. These side effects may potentially be related to Fluorouracil (fluorouracil) (fluorouracil).
Interstitial Lung Disease, Condition Aggravated

This Interstitial Lung Disease Fluorouracil (fluorouracil) (fluorouracil) side effect was reported by a health professional from KR on Dec 13, 2013. A Female , 52 years of age, was diagnosed with and was treated with Fluorouracil (fluorouracil) (fluorouracil). The patient presented the following health conditions:
  • Interstitial Lung Disease
  • Condition Aggravated
. Fluorouracil (fluorouracil) (fluorouracil) dosage: NA. Additional drugs used at the same time:
  • Oxaliplatin (oxaliplatin) (oxaliplatin)
  • Leucovorin (folinic Acid) (folinic Acid)
  • Meloxicam
The patient was hospitalized.
Interstitial Lung Disease

This is a Fluorouracil side effect report of a 59-year-old female patient (weight:NA) from JP, suffering from the following symptoms/conditions: breast cancer, who was treated with Fluorouracil (dosage:500 Mg/m2, Every Three Weeks, Intravenous (not Otherwise Specified)?, start time: NS), combined with:
  • Epirubicin (100mg/m2, Every Three Weeks, Intravenous (not Otherwise Specified)?)
  • Cyclophosphamide (500 Mg/m2, Every Three Weeks, Intravenous (not Otherwise Specified)?)
  • Paclitaxel (80 Mg/m2, Weekly, Intravenous (not Otherwise Specified)?)
, and developed a serious reaction and a Interstitial Lung Disease side effect. The patient presented with:
  • Interstitial Lung Disease
which developed after the beginning of treatment. This side effect report can indicate a possible existence of increased vulnerability to Fluorouracil treatment in female patients suffering from breast cancer, resulting in Interstitial Lung Disease.

Interstitial Lung Disease

A 45-year-old female patient (weight: NA) from JP with the following symptoms: breast cancer started Fluorouracil (fluorouracil) (fluorouracil) treatment (dosage: 500 Mg/m2, Every Three Weeks, Intravenous) on NS. Soon after starting Fluorouracil (fluorouracil) (fluorouracil) treatment, the consumer experienced several side effects, including:
  • Interstitial Lung Disease
. Concurrently used drugs:
  • Epirubicin (epirubicin) (epirubicin) (100 Mg/m2, Every Three Weeks, Intravenous)
  • Cyclophosphamide (cyclophosphamide) (cyclophosphamide) (500 Mg/m2, Every Three Weeks, Intravenous)
  • Paclitaxel (80 Mg/m2, Weekly, Intravenous)
The patient was hospitalized. This finding indicates that some patients can be more vulnerable to developing Fluorouracil (fluorouracil) (fluorouracil) side effects, such as Interstitial Lung Disease.
Interstitial Lung Disease

A female patient from JP was prescribed and started Fluorouracil on Nov 15, 2013. Patient felt the following Fluorouracil side effects: interstitial lung disease Additional patient health information: Female , 48 years of age, The consumer reported the following symptoms: was diagnosed with and. Fluorouracil dosage: NA. Concurrently used drugs:
  • Epirubicin
  • Cyclophosphamide
  • Paclitaxel
Interstitial Lung Disease

This report suggests a potential Fluorouracil Interstitial Lung Disease side effect(s) that can have serious consequences. A 63-year-old female patient from JP (weight:NA) was diagnosed with the following health condition(s): breast cancer and used Fluorouracil (dosage: NA) starting NS. Soon after starting Fluorouracil the patient began experiencing various side effects, including:
  • Interstitial Lung Disease
Drugs used concurrently:
  • Epirubicin
  • Cyclophosphamide
  • Paclitaxel
The patient was hospitalized. Although Fluorouracil demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as Interstitial Lung Disease, may still occur.
Interstitial Lung Disease

An adverse event was reported by a health professional on Nov 12, 2013 by a Female taking Fluorouracil (dosage: 500 Mg/m2, Every Three Weeks, Intravenous (not Otherwise Specified)) was diagnosed with and. Location: JP , 50 years of age, patient began experiencing various side effects, including: Directly after treatment started, patient experienced the unwanted or unexpected Fluorouracil side effects: interstitial lung disease. Additional medications/treatments:
Associated medications used:
  • Epirubicin (100 Mg/m2, Every Three Weeks, Intravenous (not Otherwise Specified)?)
  • Cyclophosphamide (500 Mg/m2, Every Three Weeks, Intravenous (not Otherwise Specified)?)
  • Paclitaxel (80 Mg/m2, Weekly, Intravenous (not Otherwise Specified)?)
The patient was hospitalized.
Interstitial Lung Disease

This Interstitial Lung Disease problem was reported by a physician from JP. A 59-year-old female patient (weight: NA) was diagnosed with the following medical condition(s): breast cancer stage iii.On NS a consumer started treatment with Fluorouracil (dosage: 500 Mg/m2, Cyclic (every 21 Days For 4 Cycles)). The following drugs/medications were being taken at the same time:
  • Paclitaxel (80 Mg/m2, Cyclic (for 12 Weeks))
  • Epirubicin (100 Mg/m2, Cyclic (every 21 Days For 4 Cycles))
  • Cyclophosphamide (500 Mg/m2, Cyclic)
When commencing Fluorouracil, the patient experienced the following unwanted symptoms /side effects:
  • Interstitial Lung Disease
Although all drugs are carefully tested before they are licensed for use, they carry potential side effect risks. Some side effects, such as Interstitial Lung Disease, may become evident only after a product is in use by the general population.
Interstitial Lung Disease

This is a Fluorouracil side effect report of a 63-year-old female patient (weight: NA) from JP. The patient developed the following symptoms/conditions: breast cancer stage ii and was treated with Fluorouracil (dosage: 500 Mg/m2, Cyclic (every 21 Days For 4 Cycles)) starting NS. Concurrently used drugs:
  • Paclitaxel (80 Mg/m2, Cyclic (for 12 Weeks))
  • Epirubicin Hydrochloride (100 Mg/m2, Cyclic (every 21 Days For 4 Cycles))
  • Cyclophosphamide (500 Mg/m2, Cyclic (every 21 Days For 4 Cycles))
Soon after that, the consumer experienced the following of symptoms:
  • Interstitial Lung Disease
The patient was hospitalized. This opens a possibility that Fluorouracil could cause Interstitial Lung Disease and that some female patients may be more susceptible.
Interstitial Lung Disease

This Interstitial Lung Disease side effect was reported by a physician from JP on Nov 26, 2013. A female patient from JP , 48 years of age, was diagnosed with and was treated with Fluorouracil. Directly after treatment started, patient experienced the unwanted or unexpected Fluorouracil side effects: interstitial lung disease. Fluorouracil dosage: 500 Mg/m2, Every 21 Days For 4 Cycles..
Associated medications used:
  • Paclitaxel (80 Mg/m2, Cyclic Once-weekly For 12 Weeks.)
  • Epirubicin Hydrochloride (100 Mg/m2 Day 1, Every 21 Days For 4 Cycles.)
  • Cyclophosphamide (500 Mg/m2, Every 21 Days For 4 Cycles.)
These side effects may potentially be related to Fluorouracil.
Interstitial Lung Disease

This Interstitial Lung Disease side effect was reported by a physician from JP. A 50-year-old female patient (weight:NA) experienced the following symptoms/conditions: breast cancer stage iii. The patient was prescribed Fluorouracil (dosage: 500 Mg/m2, Every 21 Days For 4 Cycles.), which was started on NS. Concurrently used drugs:
  • Paclitaxel (80 Mg/m2, Cyclic Once-weekly For 12 Weeks)
  • Epirubicin Hydrochloride (100 Mg/m2 Day 1, Every 21 Days For 4 Cycles.)
  • Cyclophosphamide (500 Mg/m2, Every 21 Days For 4 Cycles.)
When starting to take Fluorouracil the consumer reported the following symptoms:
  • Interstitial Lung Disease
The patient was hospitalized. These side effects may potentially be related to Fluorouracil.
Interstitial Lung Disease

This Interstitial Lung Disease Fluorouracil side effect was reported by a physician from JP on Nov 26, 2013. A Female , 45 years of age, was diagnosed with and was treated with Fluorouracil. The patient presented the following health conditions:
  • Interstitial Lung Disease
. Fluorouracil dosage: 500 Mg/m2, Cyclic (every 21 Days For 4 Cycles). Additional drugs used at the same time:
  • Paclitaxel (80 Mg/m2, Cyclic (for 12 Weeks))
  • Epirubicin Hydrochloride (100 Mg/m2, Cyclic (on Day 1) (every 21 Days For 4 Cycles))
  • Cyclophosphamide (500 Mg/m2, Cyclic (every 21 Days For 4 Cycles))
The patient was hospitalized.
White Blood Cell Count Decreased, Neutrophil Count Decreased, Interstitial Lung Disease, Disseminated Intravascular Coagulation, Respiratory Failure, Diffuse Alveolar Damage

This is a Fluorouracil side effect report of a 73-year-old patient (weight:NA) from JP, suffering from the following symptoms/conditions: colon cancer, who was treated with Fluorouracil (dosage:NA, start time: Apr 12, 2011), combined with:
  • Elplat
  • Vectibix
  • Calcium Levofolinate(calcium Levofolinate)(calciui Levofolinate)
  • Ceftriaxone Sodium(ceftriaxone Sodium)(ceftriaxon) Sodium)
  • Aloxi(palonosetron Hydrochloride)(palonosetron Hydrochloride)
  • Chlorphenamine Maleate(chlorphenamine Maleate) (chlorphenamine Maleate)
  • Dexart(dexamethasone Sodium Phosphate)(dexamethasone Sodium Phosphate)
  • Pazufloxacin(pazufloxacin)(pazufloxacin)
, and developed a serious reaction and a Interstitial Lung Disease side effect. The patient presented with:
  • White Blood Cell Count Decreased
  • Neutrophil Count Decreased
  • Interstitial Lung Disease
  • Disseminated Intravascular Coagulation
  • Respiratory Failure
  • Diffuse Alveolar Damage
which developed after the beginning of treatment. This side effect report can indicate a possible existence of increased vulnerability to Fluorouracil treatment in patients suffering from colon cancer, resulting in Interstitial Lung Disease.
Interstitial Lung Disease, Disseminated Intravascular Coagulation, White Blood Cell Count Decreased, Neutrophil Count Decreased

A 73-year-old patient (weight: NA) from JP with the following symptoms: colon cancer started Fluorouracil treatment (dosage: Regimen 1) on Oct 18, 2011. Soon after starting Fluorouracil treatment, the consumer experienced several side effects, including:
  • Interstitial Lung Disease
  • Disseminated Intravascular Coagulation
  • White Blood Cell Count Decreased
  • Neutrophil Count Decreased
. Concurrently used drugs: NA. This finding indicates that some patients can be more vulnerable to developing Fluorouracil side effects, such as Interstitial Lung Disease.
Interstitial Lung Disease

A patient from JP was prescribed and started Fluorouracil on Aug 12, 2013. After Fluorouracil was administered, patient encountered several Fluorouracil side effects: interstitial lung disease Additional patient health information: male , 79 years of age, The consumer reported the following symptoms: . Fluorouracil dosage: Unk. Concurrently used drugs:
  • Irinotecan Hcl (Unk)
  • Calcium Levofolinate (Unk)
  • Panitumumab (Unk)
Septic Shock, Interstitial Lung Disease, Disseminated Intravascular Coagulation, Neutropenia, Device Related Infection

This report suggests a potential Fluorouracil Interstitial Lung Disease side effect(s) that can have serious consequences. A 65-year-old female patient from JP (weight:NA) was diagnosed with the following health condition(s): breast cancer female and used Fluorouracil (dosage: NA) starting NS. Soon after starting Fluorouracil the patient began experiencing various side effects, including:
  • Septic Shock
  • Interstitial Lung Disease
  • Disseminated Intravascular Coagulation
  • Neutropenia
  • Device Related Infection
Drugs used concurrently:
  • Epirubicin (epirubicin) (epirubicin)
  • Cyclophosphamide
  • Paclitaxel
Although Fluorouracil demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as Interstitial Lung Disease, may still occur.
Interstitial Lung Disease, C-reactive Protein Increased, Dyspnoea, Blood Lactate Dehydrogenase Increased, Cell Marker Increased, Respiratory Failure

An adverse event was reported by a health professional on Jun 24, 2013 by a male taking Fluorouracil (dosage: Bolus) was diagnosed with and. Location: JP , 69 years of age, weighting 134.5 lb, patient began experiencing various side effects, including: Patient felt the following Fluorouracil side effects: interstitial lung disease, c-reactive protein increased, dyspnoea, blood lactate dehydrogenase increased, cell marker increased, respiratory failure. Additional medications/treatments: The patient was hospitalized.
Interstitial Lung Disease, Cytomegalovirus Enteritis, Peritonitis, Large Intestine Perforation

This Interstitial Lung Disease problem was reported by a health professional from JP. A 62-year-old patient (weight: NA) was diagnosed with the following medical condition(s): oesophageal carcinoma.On 2013 a consumer started treatment with Fluorouracil (dosage: NA). The following drugs/medications were being taken at the same time:
  • Cisplatin
  • Onetaxotere
  • Therapeutic Radiopharmaceuticals (therapeutic Radiopharmaceuticals)
When commencing Fluorouracil, the patient experienced the following unwanted symptoms /side effects:
  • Interstitial Lung Disease
  • Cytomegalovirus Enteritis
  • Peritonitis
  • Large Intestine Perforation
The patient was hospitalized. Although all drugs are carefully tested before they are licensed for use, they carry potential side effect risks. Some side effects, such as Interstitial Lung Disease, may become evident only after a product is in use by the general population.
Interstitial Lung Disease, Neuropathy Peripheral, Activities Of Daily Living Impaired, Pneumonitis

This is a Fluorouracil side effect report of a 72-year-old patient (weight: NA) from JP. The patient developed the following symptoms/conditions: rectal cancer and was treated with Fluorouracil (dosage: Intravenous (not Otherwise Specified)) starting Mar 20, 2007. Concurrently used drugs:
  • Oxaliplatin (Every Cycle, Intravenous Drip)
  • Calcium Levofolinate
  • Kytil (granisetron Hydrochloride) (granisetron Hydrochloride)
  • Decadron (dexamethasone) (dexamethasone)
  • Basen (voglibose) (voglibose)
  • Euglucon (glibenclamide) (glibenclamiide)
  • Predonine (prednisolone) (prednisolone)
  • Methylprednisolone Sodium Succinate (methylprednisone Sodium Succinate) (methylprednisolone Sodium S
Soon after that, the consumer experienced the following of symptoms:
  • Interstitial Lung Disease
  • Neuropathy Peripheral
  • Activities Of Daily Living Impaired
  • Pneumonitis
The patient was hospitalized. This opens a possibility that Fluorouracil could cause Interstitial Lung Disease and that some patients may be more susceptible.
Interstitial Lung Disease, Respiratory Distress, Condition Aggravated, Respiratory Failure

This Interstitial Lung Disease side effect was reported by a health professional from JP on Jun 28, 2013. A patient from JP , 69 years of age, was diagnosed with and was treated with Fluorouracil. Patient felt the following Fluorouracil side effects: interstitial lung disease, respiratory distress, condition aggravated, respiratory failure. Fluorouracil dosage: NA. The patient was hospitalized. These side effects may potentially be related to Fluorouracil.
1 of 5 

DISCLAIMER: ALL DATA PROVIDED AS-IS, refer to terms of use for additional information.

Fluorouracil Interstitial Lung Disease Causes and Reviews


Interstitial lung disease is the name for a large group of diseases that inflame or scar the lungs. The inflammation and scarring make it hard to get enough oxygen. The scarring is called pulmonary fibrosis.

Breathing in dust or other particles in the air is responsible for some types of interstitial lung diseases. Specific types include

  • Black lung disease among coal miners, from inhaling coal dust
  • Farmer's lung, from inhaling farm dust
  • Asbestosis, from inhaling asbestos fibers
  • Siderosis, from inhaling iron from mines or welding fumes
  • Silicosis, from inhaling silica dust

Other causes include autoimmune diseases or occupational exposures to molds, gases, or fumes. Some types of interstitial lung disease have no known cause.

Treatment depends on the type of exposure and the stage of the disease. It may involve medicines, oxygen therapy, or a lung transplant in severe cases.


Fluorouracil Interstitial Lung Disease Reviews

Wed, 28 May 2014

The side effects of Fluorouracil are most likely to be minor and temporary.InternationalDrugMart

Fri, 20 May 2011

its not 1%---more like 14% and that may even be a conservative estimate--Your doctor is lieing to you--surprised???

Sun, 13 Mar 2011

My fiancee passed away on 3/7/2011 after her second round of 5FU. The oncologist had used the words "surprised" and "out of the ordinary" on her reaction to the first round because of the amount and severity of her side effects. He still gave her the same dosage for the second round. Ten days later, she was in ICU. Seven days after going to the hospital, she was dead. She was 47 and in incredible shape except for the colon cancer. The doctor told us that she was part of the 1% of the population that didn't have the enzyme to metabolize the 5FU but she wasn't given the test because of the low percentage. With that decision, the woman I loved is no longer here.Her name was Birgit.

DISCLAIMER: ALL DATA PROVIDED AS-IS, refer to terms of use for additional information.

Common Drugs

Abilify (10132)
Adderall (1304)
Amlodipine (6664)
Amoxicillin (4387)
Benadryl (1568)
Celebrex (12876 )
Celexa (1342)
Cialis (2975)
Cipro (8580)
Citalopram (7792)
Crestor (18839)
Cymbalta (14373)
Doxycycline (1757)
Effexor (7289)
Flexeril (435)
Flomax (2177)
Fluoxetine (4261)
Gabapentin (4593)
Hydrocodone (2469)
Ibuprofen (8222)
Lantus (10968)
Lexapro (3499)
Lipitor (17769)
Lisinopril (8919)
Lyrica (27148)
Medrol (650)
Mirena (41254)
Mobic (957)
Morphine (5356)
Naproxen (538)
Neurontin (6501)
Oxycodone (4438)
Pradaxa (13372)
Prednisone (5926)
Prilosec (2631)
Prozac (1954)
Seroquel (27216)
Simvastatin (8348)
Synthroid (4452)
Tamiflu (5585)
Topamax (3748)
Tramadol (5054)
Trazodone (1458)
Viagra (5394)
Vicodin (1153)
Wellbutrin (6324)
Xanax (2847)
Zocor (5718)
Zoloft(6792)
Zyrtec(1669)

Top Fluorouracil Side Effects

Diarrhoea (463)
Nausea (335)
Dehydration (273)
Vomiting (266)
Neutropenia (243)
Febrile Neutropenia (207)
Pyrexia (187)
Mucosal Inflammation (179)
Asthenia (158)
Abdominal Pain (152)
Stomatitis (143)
Fatigue (134)
Dyspnoea (131)
Interstitial Lung Disease (117)
Decreased Appetite (116)
Pulmonary Embolism (111)
Chest Pain (110)
Anaemia (106)
Thrombocytopenia (106)
Hypotension (106)
Neutrophil Count Decreased (99)
Hypokalaemia (95)
Leukopenia (83)
Sepsis (78)
White Blood Cell Count Decreased (78)
Renal Failure Acute (75)
Pneumonia (75)
Malaise (74)
Haemoglobin Decreased (72)
Neuropathy Peripheral (69)
Pain (69)
Renal Failure (64)
Disease Progression (64)
Respiratory Failure (62)
Cardiotoxicity (62)
Dysphagia (61)
Confusional State (57)
Platelet Count Decreased (57)
Pancytopenia (55)
Fall (55)
Deep Vein Thrombosis (54)
Myocardial Infarction (53)
Arteriospasm Coronary (51)
Hyponatraemia (51)
Weight Decreased (51)
Tachycardia (48)
Chills (46)
Dizziness (46)
Septic Shock (46)
Hyperammonaemia (46)

➢ More

Discuss Fluorouracil Side Effects